Tri Locum Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,516
| Closed | -$18.4M | – | 26 |
|
|
2024
Q2 | $18.4M | Buy |
17,516
+8,949
| +104% | +$9.41M | 4.65% | 9 |
|
|
2024
Q1 | $8.25M | Sell |
8,567
-7,445
| -46% | -$7.17M | 2.86% | 15 |
|
|
2023
Q4 | $14.1M | Sell |
16,012
-3,997
| -20% | -$3.51M | 6.43% | 3 |
|
|
2023
Q3 | $16.5M | Sell |
20,009
-635
| -3% | -$523K | 5.27% | 6 |
|
|
2023
Q2 | $14.8M | Sell |
20,644
-22,745
| -52% | -$16.3M | 5.51% | 5 |
|
|
2023
Q1 | $35.7M | Buy |
+43,389
| New | +$35.7M | 10.86% | 1 |
|
|
2022
Q4 | – | Sell |
-30,115
| Closed | -$20.7M | – | 83 |
|
|
2022
Q3 | $20.7M | Buy |
+30,115
| New | +$20.7M | 5.69% | 5 |
|
|
2022
Q2 | – | Sell |
-21,477
| Closed | -$15M | – | 59 |
|
|
2022
Q1 | $15M | Buy |
+21,477
| New | +$15M | 5.86% | 3 |
|
|
2021
Q4 | – | Sell |
-13,950
| Closed | -$8.44M | – | 47 |
|
|
2021
Q3 | $8.44M | Sell |
13,950
-61,677
| -82% | -$37.3M | 3.35% | 11 |
|
|
2021
Q2 | $42.2M | Buy |
75,627
+10,922
| +17% | +$6.1M | 13.83% | 1 |
|
|
2021
Q1 | $30.6M | Buy |
64,705
+54,282
| +521% | +$25.7M | 7.59% | 1 |
|
|
2020
Q4 | $5.04M | Buy |
+10,423
| New | +$5.04M | 1.83% | 17 |
|